Patents show all

18Issued12Applications

Clinical Trials show all

2Phase 22Phase 3

SEC Filings show all

D2

SEC Form D Funding Events

DateOfferedSoldType
2010-07-23$2,502,500$1,000,999Debt, Option to Acquire, Security to be Acquired
2007-11-01UnknownUnknownOther (Paper Filing)

Key Executives

  • Brian H. Dovey
    Director
  • Donna Janson
    Executive Officer, Director
  • John J. Savarese
    Director
  • Lowell E. Sears
    Director
  • Steven J. Semmelmayer
    Director
  • Robert S. Stefanovich
    Executive Officer